Clinical heterogeneity in Fabry disease
Fabry disease is an X-linked, lysosomal storage disease (OMIM: 301500), caused by α-galactosidase A deficiency, resulting in accumulation of its substrates, glycosphingolipids, primarily – globotriaosylceramide, in the lysosomes of multiple cell types with multi-system clinical manifestations, even...
Main Author: | G. N. Salogub |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2015-12-01
|
Series: | Нервно-мышечные болезни |
Subjects: | |
Online Access: | https://nmb.abvpress.ru/jour/article/view/131 |
Similar Items
-
ОПРЕДЕЛИТЬ БОЛЕЗНЬ ФАБРИ
by: Г. П. Арутюнов, et al.
Published: (2013-04-01) -
К вопросу о значимости дозировки препаратов в ферментозаместительной терапии при болезни Фабри
Published: (2015-09-01) -
NEUROLOGICAL MANIFESTATIONS OF FABRY DISEASE IN CHILDREN AND ADOLESCENTS
by: A. S. Kotov, et al.
Published: (2017-12-01) -
METHODICAL BASES OF ESTIMATION GLOMERULAR FILTRATION RATE IN UROLOGICAL PRACTICE
by: M. M. Batiushin
Published: (2017-03-01) -
Kidney functional changes over time in liver recipients
by: E. D. Kosmacheva, et al.
Published: (2018-12-01)